[1]
Y. Wang and L. Pan, “Knockdown of CXCL3-inhibited apoptosis and inflammation in lipopolysaccharide-treated BEAS-2B and HPAEC through inactivating MAPKs pathway”, Allergol Immunopathol, vol. 50, no. 4, pp. 10–16, Jul. 2022, doi: 10.15586/aei.v50i4.621.